Skip to content

Malley Thomas Insider Trading -- Recent SEC Form 4 Transactions

Malley Thomas (CIK 1403322) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Buy KNSA (2,799 shares), Buy KURA (10,000 shares), Buy KNSA (21,959 shares), Buy KNSA (27,448 shares), Sell KNSA (49,407 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-02Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy2,799$0
2026-03-20Kura Oncology, Inc. (KURA)DirectorBuy10,000$31,200
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy21,959$40,844
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy27,448$104,302
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorSell49,407$1.6M
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy20,129$208,536
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy30,000$296,400
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorSell50,129$1.7M
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy18,760$290,217
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy33,237$476,286
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy26,236$398,525
2025-08-14Kiniksa Pharmaceuticals International, plc (KNSA)DirectorSell78,233$2.6M
2025-06-05Kiniksa Pharmaceuticals International, plc (KNSA)DirectorBuy3,173$0

Source: SEC Form 4 filings · as of 2026-06-02